Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>Epidemiological evidence indicated a relationship between vitamin D (VD) and depression with anxiety, but their therapeutic relationship has not been fully elucidated. This study aimed to examine whether VD supplementation would relieve symptoms in patients with depression and anxiety with low serum 25‐hydroxy VD [25(OH) D] levels.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Method</h3><p>Participants with low 25(OH)D levels were randomized to control or daily VD group and were followed up for 6 months. Serum concentrations of 25(OH) D were measured using commercial kits. Psychological symptoms were evaluated with the Hamilton Depression Rating Scale‐17 (HAMD‐17), Revised Social Anhedonia Scale (RSAS), Revised Physical Anhedonia scale (RPAS), and Hamilton Anxiety Rating Scale‐14 (HAMA‐14). The trial was listed in the trial registration (<a class="linkBehavior" href="http://www.medresman.org.cn/uc/index.aspx">http://www.medresman.org.cn/uc/index.aspx</a>; NTR number: ChiCTR2000030130). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>In this clinical population, no significant difference in depression symptoms was detected between VD group and control group at both baseline and at the endpoint of our study. The HAMD‐17, RSAS, and RPAS scores did not change significantly between VD and control groups from baseline to endpoint (all <i>p</i> > .05). However, there was a significant difference in time effect of the total HAMA‐14 scores between the two groups (<i>β</i> [95% Cl] = −2.235 [−3.818, −0.653], <i>p</i> = .006). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Vitamin D supplementation could improve the anxiety symptoms but not depressive symptoms in depressive patients with low VD level after the 6‐month intervention.</p></section>

Influence of Anti-hypertension No.0 on Depression in Treatment of Hypertension

Treatment Adherence As a Mediator of Blood Pressure Control in Chinese Older Adults with Depression.

Study on the long-term efficacy and safety of medicine named 'Beijing Hypertensive No. 0' in patients with primary hypertension]

Social Support and Depression Related to Older Adults’ Hypertension Control in Rural China

The Effects of Compound Antihypertensive Tablets No.0 (HTDR) on Serum Potassium, Serum Sodium and Uric Acid in Hypertension Patients in Community

Long-term Efficacy and Safety of Beijing Hypotensive No.0 in Patients with Mild to Moderate Essential Hypertension

Short-term effectiveness and safety of Compound Anti-Hypertensive Tablets (No.0) in patients with primary hypertension

Comparison of Beijing Anti-hypertension 0 and Amlodiping in Treatment Essential Hypertension

THE EFFICACY AND SAFETY OF COMPOUND ANTI-HYPERTENSIVE TABLETS (NO.0) IN PATIENTS WITH ELDERLY ISOLATED SYSTOLIC HYPERTENSION

Antihypertensive Treatment and Depressive Symptoms in Chinese Middle‐aged and Older Hypertensive Adults: A Population‐based Longitudinal Study

Distinct Effects of Antihypertensives on Depression in the Real-World Setting: A Retrospective Cohort Study.

Compound anti-hypertensive tablets (No.0) for primary hypertension:a systematic review

Antipsychotic Medications in Major Depression and the Association with Treatment Satisfaction and Quality of Life: Findings of Three National Surveys on Use of Psychotropics in China Between 2002 and 2012

The Changes In, and Relationship Between, Plasma Nitric Oxide and Corticotropin‐releasing Hormone in Patients with Major Depressive Disorder

An Initial Exploration of Hair Cortisol Responses to Antidepressants in Unmedicated Patients with Depression

Mindfulness-based intervention for hypertension patients with depression and/or anxiety in the community: a randomized controlled trial

Evaluation of the Effectiveness of the Group Interference-Management Model for Hypertension

No association between low-dose reserpine use and depression in older hypertensive patient: result of a multicenter, cross-sectional study.

Hypertensive Patients from Two Rural Chinese Counties Respond Differently to Benazepril: the Anhui Hypertension Health Care Study

[Effects of Antidepressant Therapy in Patients with Suspected "angina Pectoris" and Negative Coronary Angiogram Complicating Comorbid Depression].

Vitamin D supplementation improves anxiety but not depression symptoms in patients with vitamin D deficiency